CD95-CD95L: can the brain learn from the immune system?
Members of the tumor necrosis factor/nerve growth factor receptor superfamily of cell-surface molecules can play the dual role of mediating either cytotoxicity or cell survival, both in the immune system and in the nervous system. A member of this superfamily, CD95 (also known as ApoI or Fas), was initially identified in the immune system and has been shown to mediate receptor-dependent programmed cell death and to be expressed in the nervous system. In neurodegenerative disorders, CD95-CD95 ligand expression on glial cells might precede receptor-mediated apoptosis by cells of the CNS. It is now being recognized that CD95 signaling by immune cells mediates effects other than apoptosis, such as cell survival and under inflammatory conditions expression of this protein promotes neural-immune interactions. Both neuroscientists and immunologists can contribute to defining the mechanisms underlying these divergent effects and utilize such knowledge to aid understanding of cell death and survival.
Becher
B
B
Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Quebec, Canada.
Barker
P A
PA
Owens
T
T
Antel
J P
JP
D017209:Apoptosis / Q000502:physiology; D001921:Brain / Q000502:physiology*; D006801:Humans; D007107:Immune System / Q000502:physiology*; D008024:Ligands; D019014:fas Receptor / Q000378:metabolism*
D008024:Ligands; D019014:fas Receptor